NF1
Clinical trials for NF1 explained in plain language.
Never miss a new study
Get alerted when new NF1 trials appear
Sign up with your email to follow new studies for NF1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising drug may shrink inoperable tumors in kids with rare genetic condition
Disease control OngoingThis study tests a drug called selumetinib in children and young adults (ages 3-18) with neurofibromatosis type 1 (NF1) who have nerve tumors that cannot be removed by surgery. The goal is to see if the drug can shrink the tumors or stop them from growing. Participants take the d…
Matched conditions: NF1
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:51 UTC
-
New blood test could spot NF1 tumors without Full-Body scans
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks for substances in the blood that could signal the presence of plexiform neurofibroma tumors in people with Neurofibromatosis type 1 (NF1). Researchers will collect blood samples and use whole-body MRI scans from 200 participants to see if certain biomarkers match…
Matched conditions: NF1
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Knowledge-focused
Last updated May 26, 2026 05:51 UTC